Cerebral Inc Replaces CEO Kyle Robertson

Cerebral Inc. has replaced CEO Kyle Robertson, according to a statement released by the company. Robertson calls this move of the company illegal after accusing the board members of using him as a scapegoat for the mental-health startup's troubles.

The board said in a statement that it had replaced Robertson with the company's president and chief medical officer. The action is taken as the company faces a federal investigation into its prescribing practices and possible violations of the Controlled Substances Act.

In a memo to the board, Robertson said he encouraged the company to prescribe Adderall, which is used to treat attention deficit hyperactivity disorder, as part of the offer.

About the allegations in the memo about the increase in prescriptions, Dr. Mou claims that he doesn't know the specific context of the allegations. He added that at his recommendation, the company began using UpToDate medical software, which includes widely used treatment algorithms to help doctors treat patients.

In a labor lawsuit, a former brain executive claimed that the company prescribed stimulants for "business reasons" and prioritized profits and growth over patient safety. He said Robertson instructed company employees to track how patient retention correlates with stimulant prescriptions. Cerebral said the claim was not true and would actively protect itself.